Foschi and colleagues used botulinum toxin A (BTX) to inhibit muscle contraction in the gastric wall in morbidly obese patients and assessed the subsequent changes in food intake and body weight.

The BTX is the most recent model in LECO's Benchtop (or BT) GC-TOFMS series. The Pegasus BT series has demonstrated dependability in labs for the past eight years, completing objective, non-targeted ...